Author's reply
We welcome the comments raised in the letter by Dr Ismail and Mr Walker. The experience of their patient with an adrenal nodule secreting an unusual amount of C21-steroids, in particular 2I-deoxycortisol nicely demonstrates why the diagnosis of Cushing's syndrome continues to be a fascinating but challenging issue.
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The retrospective review of capillary gas chromatograms of patients with Cushing's syndrome was interesting. Our experience is that in patients with an elevated serum cortisol who have a plasma ACTH between lo-I5ngjmL we cannot confidently exclude an adrenal adenoma or macronodular adrenocortical hyperplasia. In Table I of our paper, macronodular adrenocortical hyperplasia is classified as 'Other' causes of hypercortisolism because it is not truly ACTH-(in)dependent.
Since the paper was submitted we have published another test (corticotrophin-releasing hormone (CRH + desmopressin I) which gives greater discrimination between pituitary-dependant ACTH and pituitary-independent ACTH. The patient described by Dr Ismail in this situation would have demonstrated a normal ACTH and cortisol response to the CRH + desmopressin test, therefore strongly suggesting this was not an adrenal lesion. This would have resulted in further scrutiny of all the clinical and biochemical information and if a diagnosis was not immediately obvious the patient's hypercortisolism would be medically managed and the clinical investigations reviewed at a later date.
Finally, the quoted algorithm and interpretations of the biochemical results should be regarded as a suggested useful programme of investigations for the screening and differential diagnosis of Cushing's syndrome. Authors' reply haematocrit range, implying concurrence with a claim that results are not affected by haematocrit in the range 2G-<i5% at a glucose level < 11·1 mmol/L, and haematrocrit in the range 25-55% at glucose levels > 11·1 mmol/L, However, there are no data in the report to show that haematocrit does not influence the result. The figures presented merely suggest that the influence is not greater than about 15% at the glucose levels and over the haematocrit ranges tested.
In an unpublished evaluation of the effect of haematocrit on the Advantage system, I found that there was indeed an effect. Blood samples from two adults were separated into cells and plasma, then recombined in various different proportions, mixed and the blood glucose measured using the Advantage. The results in Fig. I indicate a definite influence of haematocrit and this has also been demonstrated by other workers.l-' In fact, the manufacturers' own data suggest that, at a glucose concentration of about 11·0 rnmol/L, the Advantage result could deviate from this figure by roughly ± 15%, depending on where the haematocrit was in the range 2G-<i5%.
The Advantage system has been marketed as suitable from neonatal use. At present, in view of the above observations, I feel that this is not justified, although there is some evidence from Boehringer's own studies that the haematocrit effect is smaller at the low glucose levels that are of particular interest in neonates.
In our short report it was not possible to provide details of our data on the effects of haematocrit on blood glucose as measured by the Advantage meter. The details are as follows: At a blood glucose level of 5·9 mmol/L, haematocrits of 0·09, 0·25, 0·33, 0,39, 0045, 0049, 0,59, 0·64 gave mean blood glucose readings of 6,9, 604, 5,9, 6·3, 5·9, 5,8, 5,7 , 5·5 mrnol/L, respectively. Within the haematocrit range 0·25--0·64 the differences from the original glucose value ranged from -6·8% to +8,5%. At a level of Zl-l mmol/L, haematocrits of 0,09, 0·24, O· 35, 0,39, 0042, 0·57 gave mean blood glucose readings of23'7, 18·8, 21'1,20'0,2004, 18 '5mmol/L, respectively. Within the haematocrit range 0·24--Q· 57 differences from the original glucose value ranged from -12·3% to 0%. We feel that in the clinical situations in which we recommend the meter's use, this variation is acceptable. Further evaluations are currently being carried out on the use of the meter in our special care baby unit. These will include an assessment of the effects of haematocrit at the low glucose levels found in neonates.
